Delpharm’s Post

🚨 𝐑𝐞𝐩𝐥𝐚𝐜𝐢𝐧𝐠 𝐓𝐢𝐎𝟐 𝐢𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬: 𝐀 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 🚨 Since the ban on TiO2 in food supplements in August 2022, the question of replacing this crucial excipient in medicines has become increasingly urgent. Should the composition be reformulated or adapted? The answer depends on several key factors: 🔹 Pharmaceutical form: coated tablets, capsules, etc. 🔹 Role of TiO2: whitening, opacification, or UV light protection. 🔹 Retaining the original colour: is it essential for the final product? The solutions offered include either the complete removal of TiO2 or its replacement with another excipient. The best solution depends on each project and involves anticipating and adapting the formulas to meet regulatory challenges and ensure the quality of medicines. 🔬 Contact us to discuss: development@delpharm.com #regulatory #biotech #startup #delpharm